在COVID-19相关的ARDS之后,ICU对纤维变化的预测因素:RECOVIDS副研究
Matthieu Demeyere1, Isabelle Fournel2, Amadou-Khalilou Sow2
1Service de Radiologie, CHU Rouen, 76000, Rouen, France.
Annals of intensive care
|November 3, 2025
概括
肺纤维化 (PF) 影响36.8%的COVID-19 ARDS幸存者在ICU后6个月. 年龄较大,BMI<30,并发症和通风预测PF,有助于早期干预.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 放射学 放射学是一门学科.
背景情况:
- 与COVID-19相关的急性呼吸窘迫综合征 (ARDS) 幸存者面临肺纤维变化 (FC) 的风险.
- 早期识别FC的预测因素对于管理呼吸道并发症至关重要.
- 需要预测工具来优化ARDS后的患者结果.
研究的目的:
- 在COVID-19 ARDS幸存者中确定肺纤维变化 (FC) 的早期预测因素.
- 在这个患者群体中开发FC的预测工具.
- 为了描述肺纤维化的放射学模式.
主要方法:
- 一项观察性,前性,多中心研究,涉及法国和比利时的32个中心.
- 包括符合柏林标准或需要高流氧治疗的COVID-19 ARDS幸存者.
- 排除标准包括失去随访,缺少胸部CT扫描和先前存在的间歇性肺部疾病.
主要成果:
- 在440名分析患者中,162名 (36.8%) 在6个月的随访CT时显示肺FC.
- 预测FC的预测因素包括年龄较大,BMI <30,查尔森并发症指数≥1,侵入性机械通风,早期的FC症状和更大的基线肺部参与.
- 肺部FC的预测性诺基图实现了80.6%的AUC;晚期组织性肺炎是最常见的模式.
结论:
- 在COVID-19 ARDS幸存者中,很大一部分 (36.8%) 在ICU后6个月发展为肺FC.
- 确定关键预测因素可以为治疗策略和后续协议提供信息.
- 这项研究为在ARDS幸存者中管理长期呼吸系统健康提供了宝贵的见解.
相关概念视频
Factors Affecting Pulmonary Ventilation
2.8K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.8K
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-III
756
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
756
Acute Respiratory Failure-I
817
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
817
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Acute Respiratory Failure-V
443
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
443


